Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Glenn Beeman"'
Autor:
Aslihan Gerhold-Ay, Elena Svenson, Corinna M Wolf, Anja von Heydebreck, Glenn Beeman, P. Alexander Rolfe, Marcus Otte, Juergen Scheuenpflug, M. Ruisi, Ti Cai, Thomas Mrowiec, Parantu K. Shah, Hans Juergen Grote, Violeta Labarta-Beceiro
Publikováno v:
Journal of Clinical Oncology. 38:e21539-e21539
e21539 Background: Assessment of programmed death ligand-1 (PD-L1) protein expression using immunohistochemistry (IHC)-based tests is currently the only approved biomarker guiding treatment of non-small cell lung cancer (NSCLC) with checkpoint inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1871395067c3b5ae324480cb0077a92
https://doi.org/10.1200/jco.2020.38.15_suppl.e21539
https://doi.org/10.1200/jco.2020.38.15_suppl.e21539
Publikováno v:
Equine Veterinary Practitioner; Jun2024, Vol. 49 Issue 2, p13-13, 1/2p
Publikováno v:
VetScript; Feb/Mar2023, Vol. 36 Issue 1, p56-61, 6p
Autor:
Thompson, Elizabeth Anne
Publikováno v:
Equine Veterinary Practitioner; Jun2022, Vol. 47 Issue 2, p27-32, 6p
Autor:
Wendy Wolfson
Publikováno v:
Chemistry & Biology. 20:857-858
Addgene is dwarfed by nonprofit repositories such as PlasmID and its sibling DNASU. PlasmID, currently home to over 400,000 plasmids, was founded in 2004 by a consortium of Harvard research centers and hospitals, including the Dana Farber Cancer Inst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7e71ec16abfcb6bbef7d83de45e038
https://doi.org/10.1016/j.chembiol.2013.07.002
https://doi.org/10.1016/j.chembiol.2013.07.002